Tag: Generare
-
Generare secures €20M to scale molecular discovery platform
Generare, a Paris-based biotechnology company focused on generating molecular data for drug development, has raised €20 million in a Series A funding round. The round was co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures, and VIVES Partners. Drug discovery has historically been constrained to a relatively narrow chemical space, read more
Written by
